HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 129 filers reported holding HERON THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 0.18 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $135,000 | -91.5% | 54,000 | -85.6% | 0.01% | -90.8% |
Q3 2022 | $1,581,000 | +151.4% | 374,563 | +824.8% | 0.08% | +216.7% |
Q2 2021 | $629,000 | -46.7% | 40,500 | -37.9% | 0.02% | -61.3% |
Q4 2017 | $1,181,000 | +73.2% | 65,263 | +198.3% | 0.06% | +51.2% |
Q2 2015 | $682,000 | – | 21,876 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG KEVIN C | 760 | $783 | 100.00% |
Velan Capital Investment Management LP | 6,986,744 | $7,196,346 | 5.80% |
Tejara Capital Ltd | 2,109,681 | $2,172,971 | 1.23% |
JW Asset Management, LLC | 2,407,418 | $2,479,641 | 1.07% |
Rubric Capital Management LP | 26,713,503 | $27,514,908 | 1.03% |
GREAT POINT PARTNERS LLC | 4,737,368 | $4,879,489 | 0.89% |
Orchard Capital Management, LLC | 2,142,823 | $2,207,108 | 0.82% |
Clearline Capital LP | 6,149,842 | $6,334,338 | 0.54% |
CM Management, LLC | 450,000 | $463,500 | 0.49% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 327,450 | $337,274 | 0.48% |